PW Medtech Group Limited (HKG:1358)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Infusion Set	207.64M	286.65M	286.65M	248.49M	271.40M
Blood Purification	611.79M	482.26M	482.26M	288.34M	-
Regenerative Medical Biomaterials	4.07M	-	-	-	-
Total	823.51M	768.90M	768.90M	536.83M	271.40M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
India	55.95M	39.67M	24.47M	21.47M	-
America(Excluding U.S)	26.45M	21.17M	13.52M	7.56M	-
Africa Region	29.27M	18.11M	6.83M	-	-
Other Asia Countries	65.03M	36.17M	-	-	-
Others	10.85M	9.85M	24.04M	2.18M	-
China	635.96M	643.93M	606.23M	505.62M	-
Mainland China, including Hong Kong (HK)	-	-	-	-	271.40M
Total	823.51M	768.90M	675.08M	536.83M	271.40M

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error